{"id":"https://openalex.org/W2896422012","doi":"https://doi.org/10.1016/j.jalz.2018.06.2401","title":"O1\u201012\u201006: PHASE 1 MULTIPLE ASCENDING DOSE (MAD) STUDY OF PHOSPHODIESTERASE\u20109 INHIBITOR E2027: CONFIRMATION OF TARGET ENGAGEMENT AND SELECTION OF PHASE 2 DOSE IN DEMENTIA WITH LEWY BODIES","display_name":"O1\u201012\u201006: PHASE 1 MULTIPLE ASCENDING DOSE (MAD) STUDY OF PHOSPHODIESTERASE\u20109 INHIBITOR E2027: CONFIRMATION OF TARGET ENGAGEMENT AND SELECTION OF PHASE 2 DOSE IN DEMENTIA WITH LEWY BODIES","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2896422012","doi":"https://doi.org/10.1016/j.jalz.2018.06.2401","mag":"2896422012"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2018.06.2401","doi":"https://doi.org/10.1016/j.jalz.2018.06.2401","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2018.06.2401","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002542527","display_name":"Ishani Savant Landry","orcid":"https://orcid.org/0000-0002-4865-4754","observed_orcids":["https://orcid.org/0000-0002-4865-4754"]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ishani Landry","raw_affiliation_strings":["Eisai Inc., Woodcliff Lake, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc., Woodcliff Lake, NJ, USA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113065527","display_name":"Robert Y. K. Lai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148122","display_name":"Eisai (United Kingdom)","ror":"https://ror.org/054j7wb83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210148122","https://openalex.org/I55881946"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robert YK. Lai","raw_affiliation_strings":["Eisai Ltd., Hatfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Ltd., Hatfield, United Kingdom","institution_ids":["https://openalex.org/I4210148122"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Peter Boyd","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148122","display_name":"Eisai (United Kingdom)","ror":"https://ror.org/054j7wb83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210148122","https://openalex.org/I55881946"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter Boyd","raw_affiliation_strings":["Eisai Ltd., Hatfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Ltd., Hatfield, United Kingdom","institution_ids":["https://openalex.org/I4210148122"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113714866","display_name":"Jagadeesh Aluri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jagadeesh Aluri","raw_affiliation_strings":["Eisai Inc., Woodcliff Lake, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc., Woodcliff Lake, NJ, USA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113852041","display_name":"Min\u2010Kun Chang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Min-Kun Chang","raw_affiliation_strings":["Eisai Inc., Woodcliff Lake, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc., Woodcliff Lake, NJ, USA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045365891","display_name":"Mitsuhiro Ino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsuhiro Ino","raw_affiliation_strings":["Eisai Co. Ltd., Tsukuba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Co. Ltd., Tsukuba, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088109475","display_name":"Kanta Horie","orcid":"https://orcid.org/0000-0001-7736-2614","observed_orcids":["https://orcid.org/0000-0001-7736-2614"]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kanta Horie","raw_affiliation_strings":["Eisai Co. Ltd., Tsukuba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Co. Ltd., Tsukuba, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010189987","display_name":"Edgar L. Schuck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edgar L. Schuck","raw_affiliation_strings":["Eisai Inc., Woodcliff Lake, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc., Woodcliff Lake, NJ, USA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028315849","display_name":"Johan Luthman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Johan Luthman","raw_affiliation_strings":["Eisai Inc., Woodcliff Lake, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc., Woodcliff Lake, NJ, USA","institution_ids":["https://openalex.org/I4210151718"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5002542527"],"corresponding_institution_ids":["https://openalex.org/I4210151718"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.078,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.3499814,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"14","issue":"7S_Part_4","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.010499999858438969,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7585664987564087},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7438838481903076},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6162766218185425},{"id":"https://openalex.org/C62826618","wikidata":"https://www.wikidata.org/wiki/Q424304","display_name":"Phosphodiesterase","level":3,"score":0.6150097250938416},{"id":"https://openalex.org/C2780994212","wikidata":"https://www.wikidata.org/wiki/Q422511","display_name":"Cyclic guanosine monophosphate","level":3,"score":0.5565457344055176},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5431929230690002},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5267060399055481},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5168145895004272},{"id":"https://openalex.org/C2776766087","wikidata":"https://www.wikidata.org/wiki/Q418251","display_name":"Phosphodiesterase inhibitor","level":2,"score":0.4381096661090851},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4248094856739044},{"id":"https://openalex.org/C79410662","wikidata":"https://www.wikidata.org/wiki/Q1251001","display_name":"Dose\u2013response relationship","level":2,"score":0.4227564334869385},{"id":"https://openalex.org/C2777995097","wikidata":"https://www.wikidata.org/wiki/Q422462","display_name":"Guanosine","level":2,"score":0.4135643541812897},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.352183073759079},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33668816089630127},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2688027024269104},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.21021145582199097},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11566299200057983},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10141611099243164},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2018.06.2401","doi":"https://doi.org/10.1016/j.jalz.2018.06.2401","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2018.06.2401","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2897249465","https://openalex.org/W2766188293","https://openalex.org/W4406224134","https://openalex.org/W2579907512","https://openalex.org/W2028090596","https://openalex.org/W7155416978","https://openalex.org/W1980520882","https://openalex.org/W4408849120","https://openalex.org/W2027964982","https://openalex.org/W2923763995"],"abstract_inverted_index":{"E2027":[0,23,93,144,165,197,281],"is":[1,36,308],"a":[2,57,82,176,202,264],"novel,":[3],"highly":[4],"selective":[5],"and":[6,35,62,76,125,127,133,137,172,193,273,298,320],"potent":[7],"inhibitor":[8],"of":[9,53,60,158,190,206,223,271,276,291],"phosphodiesterase-9":[10],"(PDE9)":[11],"in":[12,32,44,81,87,175,211,231,236,244,267,301,315],"development":[13],"for":[14,67,103,112,252,310],"dementia":[15],"with":[16,106,146,201,216],"Lewy":[17],"bodies":[18],"(DLB).":[19],"By":[20],"inhibiting":[21],"PDE9,":[22],"aims":[24],"to":[25,39,50,63,98,152,225,249,256,287,317],"restore":[26],"cyclic":[27],"guanosine":[28],"monophosphate":[29],"(cGMP)":[30],"levels":[31,149],"the":[33,65,68,107,143,159,199,311],"brain":[34,200],"thereby":[37],"postulated":[38],"potentially":[40],"provide":[41,318],"symptomatic":[42],"benefits":[43],"DLB":[45,316],"patients.":[46],"This":[47],"study":[48,86,314],"aimed":[49],"establish":[51,64],"proof":[52],"target":[54,292],"engagement":[55,293],"over":[56],"prolonged":[58],"duration":[59],"treatment":[61],"dose":[66,110,145,154,161],"Phase":[69,312],"2":[70,313],"program.":[71],"Safety,":[72],"tolerability,":[73],"pharmacokinetics":[74],"(PK)":[75],"pharmacodynamics":[77],"(PD)":[78],"were":[79,101,130,283],"assessed":[80],"randomized,":[83],"placebo-controlled":[84],"MAD":[85],"healthy":[88],"subjects":[89],"(aged":[90],"50\u201385).":[91],"Daily":[92],"doses":[94,222,237,282],"ranging":[95],"from":[96],"5":[97],"400":[99,288],"mg":[100,109,306],"administered":[102,111],"14":[104,124],"days":[105,189,258],"50":[108,226,240,305],"42":[113,126],"days.":[114],"PK":[115],"was":[116,150,163,166,181,185,195,214,234,247,294],"determined":[117],"using":[118],"plasma":[119],"collected":[120,131],"on":[121,134],"Days":[122,135],"1,":[123],"CSF":[128,147,212,232,245,268,302,322],"samples":[129],"predose,":[132],"13":[136],"41.":[138],"The":[139,156,242,260],"PK/PD":[140,261],"relationship":[141],"correlating":[142],"cGMP":[148,213,233,246,269,323],"modeled":[151],"support":[153],"selection.":[155],"90%":[157],"effective":[160],"(ED90)":[162],"estimated.":[164],"rapidly":[167],"absorbed":[168],"(tmax":[169],"2\u20134":[170],"hr)":[171],"exposure":[173],"increased":[174],"dose-dependent":[177,209,297],"manner.":[178],"Elimination":[179],"half-life":[180],"40":[182],"hours,":[183],"steady-state":[184],"reached":[186],"within":[187],"7":[188],"daily":[191,221,280],"dosing,":[192],"accumulation":[194],"2.8-fold.":[196],"penetrated":[198],"CSF:plasma":[203],"concentration":[204],"ratio":[205],"3.5%.":[207],"A":[208],"increase":[210,230,243,266],"demonstrated":[215],"maximal":[217,265,319],"effect":[218],"achieved":[219],"after":[220],"up":[224,255,286],"mg.":[227,241,278,289],"No":[228],"further":[229],"noted":[235],"higher":[238],"than":[239],"confirmed":[248,295],"be":[250],"sustained":[251,299,321],"at":[253],"least":[254],"41":[257],"postdose.":[259],"model":[262],"estimated":[263],"(Emax)":[270],"220%,":[272],"an":[274],"ED90":[275],"36":[277],"Multiple":[279],"well":[284],"tolerated":[285],"Proof":[290],"by":[296],"increases":[300],"cGMP.":[303],"Once-daily":[304],"dosing":[307],"recommended":[309],"elevation.":[324]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-10-26T00:00:00"}